glp 1 clinical trials sign up Boston biotech secures Series A funding to move its once-weekly GLP-1 obesity patch into first-in-human trials. ㅤ Link in bio. ㅤ #longevity #obesity #glp1 #clinicaltrials #biotech glp-1 clinical trials recruiting 📣

For Research Use Only Not intended for human consumption or therapeutic use

If the weight maintenance observed in these preclinical studies is validated in humans, TIX100 could become a novel, non-GLP-1 option to support sustained weight management after medical weight loss intervention, addressing this important unmet need in the treatment of overweight and obesity, Shalev said

The lines are going down, and the semaglutide line is lower

Idiopathic guttate hypomelanosis typically presents as smooth pale (hypopigmented) or white (depigmented) macules 25mm (range up to 1.5cm) in diameter most commonly on the sun-exposed aspects of the forearms, shins, and V of chest

N Engl J Med (2020) 383(12):111728

Ngi li xe v vn hnh my mc c dng c khng